QSAR Analysis for ADA upon Interaction with a Series of Adenine Derivatives as Inhibitors

Nucleosides, Nucleotides and Nucleic Acids

Volumn 23, Issue 3, 2004, Pages 613-624

  Moosavi Movahedi, A A ^a   Safarian, S ^a   Hakimelahi, G H ^b   Ataei, G ^a,c   Ajloo, D ^a,d   Panjehpour, S ^a   Riahi, S ^e   Mousavi, M F ^e   Mardanyan, S ^f   Soltani, N ^g   Khalafi Nezhad, A ^g   Sharghi, H ^g   Moghadamnia, H ^c   Saboury, A A ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b INSTITUTE OF CHEMISTRY   (Taiwan)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d DAMGHAN UNIVERSITY   (Iran)

^e TARBIAT MODARES UNIVERSITY   (Iran)

^f H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

^g SHIRAZ UNIVERSITY   (Iran)

Author keywords

Adenine nucleosides; Adenosine deaminase; Cyclic and acyclic adenosine derivatives; QSAR analysis

Indexed keywords

ADENINE DERIVATIVE; ADENOSINE DEAMINASE; BUFFER; NUCLEOSIDE; SODIUM DIHYDROGEN PHOSPHATE;

ARTICLE; BINDING AFFINITY; CATTLE; CHEMICAL STRUCTURE; DIPOLE; ELECTRICITY; KINETICS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM MECHANICS;

ADENINE; ADENOSINE DEAMINASE; HUMANS; MOLECULAR STRUCTURE; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STATISTICS;

ADA; BOS TAURUS;

EID: 11144353585     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120030719     Document Type: Article

References (23)

1. Trotta, P.P.; Smithwick, E.M.; Balis, M.E. A normal level of adenosine deaminase activity in the red cell lysates of carriers and patients with severe combined immunodeficiency disease. Proc. Natl. Acad. Sci. U. S. A. 1976, 73, 104-108.
2. Kredich, N.M.; Hershfield, M. The Metabolic Basis of Inherited Disease; Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Eds.; Mc Graw-Hill: New York, 1989; 1045-1075.
3. Lee, P.C. Developmental changes of adenosine deaminase, xanthine oxidase, and uricase in mouse tissues. Dev. Biol. 1973, 31, 227-233.
4. Chinsky, J.M.; Ramamurthy, V.; Fanslow, W.C.; Ingolia, D.E.; Blackburn, M.R.; Shaffer, K.T.; Higley, H.R.; Trentin, J.J.; Rudolph, F.B.; Knudsen, T.B. Developmental expression of adenosine deaminase in the upper alimentary tract of mice. Differentiation 1990, 42, 172-183.
5. Marrone, T.J.; Straatsma, T.P.; Briggs, J.M.; Wilson, D.K.; Quiocho, F.A.; McCammon, J.A. Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin. J. Med. Chem. 1996, 39, 277-284.
6. Schaeffer, H.J.; Johnson, R.N.; Odin, E.; Hansch, C. Structure-activity relationships. Adenosine deaminase inhibitors. J. Med. Chem. 1970, 13, 452-455.
7. Kasibhatla, S.R.; Bookser, B.C.; Probst, G.; Appleman, J.R.; Erion, M.D. AMP deaminase inhibitors. 3. SAR of 3-(carboxyarylalkyl)coformycin aglycon analogues. J. Med. Chem. 2000, 43, 1508-1518.
8. Kasibhatla, S.R.; Bookser, B.C.; Xiao, W.; Erion, M.D. AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series. J. Med. Chem. 2001, 4, 613-618.
9. Hansch, C. Quantitative structure-activity relationships in drug design. In Drug Design; Ariens, E.J., Ed.; Academic Press: New York, 1971; 271-342.
10. Herman, R.B. Theory of hydrophobic bonding. II. The correlation of hydrocarbon solubility in water with solvent cavity surface area. J. Phys. Chem. 1972, 76, 2754-2759.
11. Herman, R.B. Theory of hydrophobic bonding. III. A method for the calculation of the hydrophobic interaction based on liquid state perturbation theory and a simple liquid model. J. Phys. Chem. 1975, 79, 163-169.
12. Kauzmann, W. Some factors in the interpretation of protein denaturation. Adv. Protein Chem. 1959, 14, 1-63.
13. Fujita, T.; Iwasa, J.; Hansch, C. A new substituent, π, derived from partition coeficients. J. Am. Chem. Soc. 1964, 86, 5175-5180.
14. Segel, I.H. Enzyme Kinetics; John Wiley & Sons: New York, 1975.
15. Gupta, S.P. Quantitative structure-activity relationship studies on local anesthetics. Chem. Rev. 1991, 91, 1109-1118.
16. Hadjipavlou-Litina, D.; Hansch, C. Quantitative structure-activity relationships of the benzodiazepines. Chem. Rev. 1994, 94, 1483-1505.
17. Zhang, L.; Gao, H.; Hansch, C.; Selassie, C.D. Molecular orbital parameters and comparative QSAR in the analysis of phenol toxicity to leukemia cells. J. Chem. Soc., Perkin Trans. 2 1998, (11), 2553-2556.
18. Moosavi-Movahedi, A.A.; Rahmani, Y.; Hakimelahi, G.H. Thermodynamic and kinetic studies of competitive inhibition of adenosine deaminase by ring opened analogues of adenine nucleoside. Int. J. Biol. Macromol. 1993, 15, 125-129.
19. Hakimelahi, G.H.; Moosavi-Movahedi, A.A.; Sadeghi, M.M.; Tsay, S.; Hwu, J. Design, synthesis, and structure-activity relationship of novel dinucleotide analogs as agents against herpes and human immunodeficiency viruses. J. Med. Chem. 1995, 38, 4648-4659.
20. Maury, G.; Daiboun, T.; Elalaoui, A.; Cenu-Dellac, C.; Perigaud, C.; Bergogne, C.; Gosselin, G.; Imbach, J.L. Inhibition and substrate specificity of adenosine deaminase interaction with 2′-3′- and 5′-substituted adenine nucleoside derivatives. Nucleosides Nucleotides 1991, 10, 1677-1692.
21. Hampton, A.; Harper, P.J.; Sasaki, T. Evidence for the conformation of enzyme-bound adenosine 5′-phosphate. Substrate and inhibitor properties of 8,5′-cycloadenosine 5′-phosphate with adenylate kinase, adenylate aminohydrolase, adenylosuccinate lyase, and 5′-nucleotidase. Biochemistry 1972, 11, 4965-4969.
22. Hakimelahi, G.H.; Zarrinehzad, M.; Jarrahpour, A.A.; Sharghi, H. 26. Ring-open analogues of adenine nucleoside. Aminoacyl derivatives of cyclo- and acyclonucleosides. Helv. Chim. Acta 1987, 70, 219-221.
23. Khorshidi, A. Doctoral thesis; Faculty of Pharmacy, Isfahan University, Iran.